Companies and technicians that are developing new algorithms to help researches and professionals to diagnose and measure diseases progression...
For centuries, MS was recognized as a condition characterized by episodic and progressive neurological deterioration, classified as ‘paraplegia’
It is difficult to diagnose Parkinson’s disease, and the only way to confirm diagnosis is postmortem. The new imaging AI tools could be the answer.
The neuro tech has speed up in the recent years and staying on top of trends is becoming a must in the neuro research. Choosing the right tech when...
Boston, MA, 29/11/21 QMENTA announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its QMENTA Platform for...
We’re thrilled to be back at RSNA 2021, and it is very fitting that it is the first in-person event we have attended since the pandemic. QMENTA has...
The importance of Data Protection and Data Integrity in Imaging Clinical Trials
QMENTA Launches World Leading Neurology Catalog and Marketplace of AI Imaging Biomarker Analysis Catalog for Medical Imaging Analyses
QMENTA CEO Vesna Prchkovska wins Gold Female Entrepreneur of the Year in the 2021 STEVIE AWARDS FOR WOMEN IN BUSINESS